畜牧兽医学报 ›› 2021, Vol. 52 ›› Issue (1): 154-165.doi: 10.11843/j.issn.0366-6964.2021.016

• 预防兽医 • 上一篇    下一篇

共表达牛病毒性腹泻病毒E0基因和牛传染性鼻气管炎病毒gD基因的重组质粒DNA构建及其对小鼠的免疫效应

马小静, 李梦莹, 张淮瑜, 宋阿北, 许立华, 吴心华, 张巧娥, 李继东*   

  1. 宁夏大学 农学院, 银川 750021
  • 收稿日期:2020-05-25 出版日期:2021-01-23 发布日期:2021-01-19
  • 通讯作者: 李继东,主要从事兽医微生物学与免疫学研究,E-mail:lijidongi@foxmail.com
  • 作者简介:马小静(1995-),女,宁夏固原人,硕士生,主要从事畜禽传染病的诊断与防治研究,E-mail:1229742938@qq.com
  • 基金资助:
    宁夏回族自治区重点研发计划东西部科技合作项目(2017BY078);“十三五”国家重点研发计划项目(2018YFD0501700);宁夏回族自治区重点研发计划项目(2018BBF33003);宁夏自然科学基金项目(2018AAC03011);宁夏回族自治区育种专项(2019NYYZ05)

Construction of a Recombinant Plasmid Co-expressing Bovine Viral Diarrhea Virus E0 Gene and Infectious Bovine Rhinotracheitis Virus gD Gene and Consider Its Immune Effect on Mice

MA Xiaojing, LI Mengying, ZHANG Huaiyu, SONG Abei, XU Lihua, WU Xinhua, ZHANG Qiaoe, LI Jidong*   

  1. School of Agriculture, Ningxia University, Yinchuan 750021, China
  • Received:2020-05-25 Online:2021-01-23 Published:2021-01-19

摘要: 本研究计划构建能同时表达牛病毒性腹泻病毒(BVDV)和牛传染性鼻气管炎病毒(IBRV)优势抗原基因的重组质粒并研究其免疫效果,旨在为BVD-IBR二联核酸疫苗的研制提供参考。采用PCR扩增目的基因E0及gD并将其依次连接至真核表达载体pVAX1-IRES中,构建pVAX1-E0-IRES-gD重组真核表达载体;将pVAX1-E0-IRES-gD转染至293T细胞中,间接免疫荧光法检测目的基因在细胞中的表达情况;将pVAX1-E0-IRES-gD以不同剂量采用肌内注射的方式接种小鼠,通过抗体水平和细胞因子检测以及脾淋巴细胞增殖试验对该重组质粒的免疫效果进行评价。结果表明,成功构建pVAX1-E0-IRES-gD重组质粒,目的基因在293T细胞内成功表达。在抗体和细胞因子水平以及脾淋巴细胞增殖能力这3个指标,重组质粒组均极显著高于空载体和阴性对照组,高剂量免疫组优于中、低剂量组;另外,高剂量重组质粒免疫组与二联灭活疫苗组相比无显著性差异。结果显示,成功构建了共表达BVDV E0和IBRV gD基因的重组质粒,体外表达检测证明目的蛋白具有良好的反应原性,动物免疫试验证明其能刺激机体产生良好免疫应答。

关键词: 牛病毒性腹泻病毒, E0, 牛传染性鼻气管炎病毒, gD, 重组质粒, 共表达, 免疫效果

Abstract: This study aimed to construct a recombinant plasmid that can simultaneously express the dominant antigen genes of bovine viral diarrhea virus (BVDV) and infectious bovine rhinotracheitis virus (IBRV), and study its immune effect, so as to provide reliable data and theoretical support for the development of BVD-IBR bivalent DNA vaccine. In our experiment, PCR was used to amplify the target genes, E0 and gD, which were sequentially connected to the eukaryotic expression vector pVAX1-IRES to construct the pVAX1-E0-IRES-gD recombinant eukaryotic expression vector. The recombinant plasmid pVAX1-E0-IRES-gD was transfected into 293T cells and the expression of the target genes in foreign cells were detected by indirect immunofluorescence assay. Following, immunization test with the pVAX1-E0-IRES-gD, pVAX1-IRES and BVD-IBR combined inactivated vaccine was inoculated with SPF mice at different doses by intramuscular injection, subsequently, immune effects have been evaluated through antibody level and cytokine detection and splenic lymphocyte proliferation assay. The results showed that the pVAX1-E0-IRES-gD recombinant plasmid was successfully constructed and both antigen genes obtained a high level of expression in 293T cells. In terms of antibody and cytokine levels and the proliferation of spleen lymphocytes, the recombinant plasmid group was significantly higher than that of the empty vector and the negative control group, and the differences were extremely significant, the high-dose immunization group was better than the medium and low dose groups. Also, the high-dose recombinant plasmid immunization group was not significantly different from the BVD-IBR inactivated vaccine group. The results showed that the co-expression recombinant plasmid which contains the BVDV E0 gene and IBRV gD gene was constructed successfully. The expression test in vitro proved that the target protein has good reactionogenicity, and animal immunity tests proved that it can stimulate the body to produce a good immune response.

Key words: bovine viral diarrhea virus, E0, infectious bovine rhinotracheities virus, gD, recombinant plasmid, co-expression, immune effect

中图分类号: